Phosphorothioate oligodeoxynucleotides can selectively alter neuronal activity in the cochlea (Q38320395)

2 September 2017

title

Phosphorothioate oligodeoxynucleotides can selectively alter neuronal activity in the cochlea (English)

1 reference

2 September 2017

LeBlanc CS

1 reference

2 September 2017

Fallon M

1 reference

2 September 2017

Parker MS

1 reference

2 September 2017

Skellett R

1 reference

2 September 2017

Bobbin RP

1 reference

2 September 2017

language of work or name

1 reference

1 September 1999

1 reference

2 September 2017

1 reference

2 September 2017

volume

135

1 reference

2 September 2017

issue

1-2

1 reference

2 September 2017

page(s)

105-112

1 reference

Cytotoxicity and mitogenicity of adenosine triphosphate in the cochlea

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2899%2900093-3

7 January 2021

Osmotic pump implant for chronic infusion of drugs into the inner ear.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2899%2900093-3

7 January 2021

Antisense oligonucleotide-induced block of individual GABAA receptor α subunits in cultured visual cortex slices reduces amplitude of evoked inhibitory postysynaptic currents

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2899%2900093-3

7 January 2021

Overview. Purinergic mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2899%2900093-3

7 January 2021

Additional pharmacological evidence that endogenous ATP modulates cochlear mechanics

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2899%2900093-3

7 January 2021

Antisense oligonucleotides to the GluR2 AMPA receptor subunit modify excitatory synaptic transmission in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2899%2900093-3

7 January 2021

Neurotransmitters and neuromodulators of the mammalian cochlea

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2899%2900093-3

7 January 2021

Facilitating oligonucleotide delivery: helping antisense deliver on its promise

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2899%2900093-3

7 January 2021

Oligodeoxynucleotides as antisense inhibitors of gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2899%2900093-3

7 January 2021

Extracellular nucleotide signaling in the inner ear.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2899%2900093-3

7 January 2021

Effects of adenosine 5'-triphosphate and related agonists on cochlear function

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2899%2900093-3

7 January 2021

ATP antagonists cibacron blue, basilen blue and suramin alter sound-evoked responses of the cochlea and auditory nerve

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2899%2900093-3

7 January 2021

Time-varying alterations in the f2-f1 DPOAE response to continuous primary stimulation. I: Response characterization and contribution of the olivocochlear efferents

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2899%2900093-3

7 January 2021

Cell delivery and mechanisms of action of antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2899%2900093-3

7 January 2021

Novel variant of the P2X2 ATP receptor from the guinea pig organ of Corti.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2899%2900093-3

7 January 2021

Blockade of morphine analgesia by an antisense oligodeoxynucleotide against the mu receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2899%2900093-3

7 January 2021

Effects of synthetic oligonucleotides on human complement and coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2899%2900093-3

7 January 2021

Pharmacological evidence that endogenous ATP modulates cochlear mechanics

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2899%2900093-3

7 January 2021

Antisense Oligodeoxynucleotides to the Cloned δ Receptor DOR‐1: Uptake, Stability, and Regulation of Gene Expression

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2899%2900093-3

7 January 2021

Stability, clearance, and disposition of intraventricularly administered oligodeoxynucleotides: implications for therapeutic application within the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2899%2900093-3

7 January 2021

Antisense oligodeoxynucleotide reduces brain dopamine D2 receptors: behavioral correlates

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2899%2900093-3

7 January 2021

10.1016/S0378-5955(99)00093-3

Identifiers

DOI

1 reference

2 September 2017

1 reference